In This Section:
Obesity
The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.
Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.
Video
A Michael Lincoff , Harriette Van Spall,
Video
Video
Harriette Van Spall, Mikhail Kosiborod,
Video
Mirvat Alasnag, Khaled Al-Shaibi,
Video Series
Fausto J Pinto, John Spertus, , et al
Broadcast
e-SPACE CRM 2023 – Day TwoStefan Anker, Javed Butler, Shelley Zieroth, et al
Broadcast
e-SPACE CRM 2023 – Day OneStefan Anker, Javed Butler, Shelley Zieroth, et al
Video Series
Yassir Javaid, , , et al
Recent Videos
Video
A Michael Lincoff , Harriette Van Spall,
Video
Radcliffe Content
European Cardiology Review 2020;15:e04.
European Cardiology Review 2020;15:e37.
European Cardiology Review 2020;15:e45.
European Cardiology Review 2019;14(1):60–1
European Cardiology Review 2018;13(2):93–4.
European Cardiology Review 2016;11(1):29–35
European Cardiology Review 2015;10(1):6–8
European Cardiology 2011;7(4):257–63
European Cardiology 2011;7(3):160–3
European Cardiology 2009;5(2):34–9